Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. 9-519-S11
Spanish language
Subject category: Marketing
Published by: Harvard Business Publishing
Originally published in: 1990
Version: 14 December 1990

Abstract

This is a Spanish version. Examines the decision by Pharma International on whether to launch an antimalarial product in Nigeria and, if so, how that should be implemented. Involves commercial, ethical, and policy considerations. Rich in situation assessment data, the case refers to criticism of pharmaceutical marketing practices in the Third World and CIBA-GEIGY's Servipharm initiative, one response to this problem.
Locations:
Industry:
Size:
70,000 employees
Other setting(s):
1983

About

Abstract

This is a Spanish version. Examines the decision by Pharma International on whether to launch an antimalarial product in Nigeria and, if so, how that should be implemented. Involves commercial, ethical, and policy considerations. Rich in situation assessment data, the case refers to criticism of pharmaceutical marketing practices in the Third World and CIBA-GEIGY's Servipharm initiative, one response to this problem.

Settings

Locations:
Industry:
Size:
70,000 employees
Other setting(s):
1983

Related